Premenstrual Dysphoric Disorder Awareness and Research Act of 2026

Expanded Research and Treatment: The bill directs the NIH to intensify research into the causes, diagnosis, and treatment of PMDD, and supports clinical trials to develop better treatment options (Section 3(a)).

Increased Representation: Research efforts are directed to ensure that diverse racial, ethnic, and socioeconomic populations are adequately represented (Section 3(a)).

Better Data Collection: The Secretary is tasked with collecting and publishing data regarding the prevalence of PMDD and its economic and workforce impacts (Section 3(b)).

Public Awareness and Stigma Reduction: A public health campaign will be used to raise awareness among patients and providers, which aims to reduce the stigma of menstrual health conditions (Section 4(a)).

Improved Provider Knowledge: The bill mandates the development of education materials so that health care providers can more accurately diagnose PMDD and provide evidence-based care (Section 4(b)).

Professional Training Programs: Through grants, the Secretary can expand or establish training programs for various health care professionals, including physicians, nurses, and pharmacists, to improve PMDD management (Section 5(c)).

Expanded Health Services: Training opportunities may be expanded to support primary and specialty care services for mid-life women's health and related chronic conditions (Section 5(e)).